on MEDIAN TECHNOLOGIES (EPA:ALMDT)
Median Technologies to Attend 2024 ASCO Annual Meeting in Chicago
Median Technologies announced its participation in the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. The event will take place from May 31 to June 4 at McCormick Place, Chicago, IL, USA. Median’s team, alongside representatives from iCRO and eyonis™, will be present at booth #15142 from June 1 to 3, between 9:00 am and 5:00 pm.
An abstract from Median Technologies has also been selected for online publication on the ASCO platform. The abstract (#e23010) discusses the impact of double reading performance and adjudication on progression-free survival estimates in lung cancer clinical trials.
The ASCO Annual Meeting is a major event in the oncology field, attracting over 35,000 oncologists and stakeholders globally. The conference provides a key platform for medical, educational, and industrial collaborations in oncology.
R. P.Copyright © 2024 FinanzWire, all reproduction and representation rights reserved. Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all MEDIAN TECHNOLOGIES news